Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab

Published:2021-11 Issue:11 Volume:21 Page:e845-e849
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Freyer Craig W.,Bange Erin M.,Skuli Sarah,Hsu Miles,Lin John,Cuker Adam,Cohen Adam D.,Garfall Alfred

Funder

Leukemia and Lymphoma Society

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Syndromes of thrombotic microangiopathy;George;New Engl J Med,2014

2. Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom;Taylor;Br J Haematol,2009

3. Clinical guidelines for atypical hemolytic uremic syndrome in Japan;Kato;Pediatr Int,2016

4. Proteasome inhibitor associated thrombotic microangiopathy;Yui;Am J Hematol,2016

5. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous CFHR3-CFHR1 deletion;Portuguese;Blood Adv,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes;Nephrology Dialysis Transplantation;2024-04-24

2. A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy;CEN Case Reports;2024-02-29

3. Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review;Kidney and Dialysis;2022-12-12

4. Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis;Journal of Medical Cases;2022-06

5. Carfilzomib-induced thrombotic microangiopathy. A case report;Journal of Oncology Pharmacy Practice;2021-12-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3